Preparing Pharmaceutical Manufacturers: Prescription Drug Price Transparency Laws Update

The first drug transparency law was passed nearly a decade ago in Vermont. Since then, over 20 other states have implemented their own drug price transparency requirements. These laws promote transparency by requiring pharmaceutical companies to report prescription drug prices and sometimes even provide advance notification to purchasers of planned drug price increases. Noncompliance triggers substantial statutory penalties and some states have already begun aggressive enforcement with delinquent companies expected to pay sanctions in […]

By | March 5th, 2022 ||

Alston & Bird Health Care Week In Review, February 25, 2022

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.

Week in Review Highlight of the Week:
This week, HHS issued more than $560 million in PRF Phase 4 General Distribution payments and CMS announced the ACO Realizing Equity, Access, and Community Health (REACH) Model. Read more about these […]

By | March 2nd, 2022 ||

Delaware Advances COVID-19 Vaccination Requirements For Health Care And State Employees

On August 12, Delaware Governor John Carney ordered all state employees and health care workers to be vaccinated for COVID-19 on or before September 30 or submit to regular COVID-19 testing.1 Additionally, he encouraged private businesses to impose similar requirements upon their employees and emphasized that many Delaware companies have already acted to do so.2 While not an official Executive Order, the Governor’s office indicated that regulations enforcing the requirements will be posted shortly. The order […]

By | February 24th, 2022 ||